Canada markets closed

Nanobiotix S.A. (NBTX)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.32-0.18 (-2.77%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 298.86M
Enterprise Value 271.97M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.14
Price/Book (mrq)65.02
Enterprise Value/Revenue 8.32
Enterprise Value/EBITDA -2.45

Trading Information

Stock Price History

Beta (5Y Monthly) 1.23
52-Week Change 325.90%
S&P500 52-Week Change 324.52%
52 Week High 311.00
52 Week Low 34.89
50-Day Moving Average 36.34
200-Day Moving Average 36.97

Share Statistics

Avg Vol (3 month) 329.42k
Avg Vol (10 day) 33.77k
Shares Outstanding 547.11M
Implied Shares Outstanding 647.29M
Float 822.79M
% Held by Insiders 10.00%
% Held by Institutions 119.76%
Shares Short (May 15, 2024) 454.52k
Short Ratio (May 15, 2024) 40.67
Short % of Float (May 15, 2024) 4N/A
Short % of Shares Outstanding (May 15, 2024) 40.12%
Shares Short (prior month Apr 15, 2024) 452.7k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -109.64%
Operating Margin (ttm)3.46%

Management Effectiveness

Return on Assets (ttm)-19.72%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)36.21M
Revenue Per Share (ttm)0.98
Quarterly Revenue Growth (yoy)854.90%
Gross Profit (ttm)N/A
EBITDA -23.69M
Net Income Avi to Common (ttm)-39.7M
Diluted EPS (ttm)-1.17
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)75.28M
Total Cash Per Share (mrq)1.6
Total Debt (mrq)50.56M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.75
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-12.48M
Levered Free Cash Flow (ttm)-5.27M